Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9

被引:559
|
作者
Wu, Yuxuan [1 ]
Liang, Dan [1 ,2 ]
Wang, Yinghua [1 ,2 ]
Bai, Meizhu [1 ,3 ]
Tang, Wei [4 ]
Bao, Shiming [5 ]
Yan, Zhiqiang [5 ]
Li, Dangsheng [6 ]
Li, Jinsong [1 ,3 ]
机构
[1] Chinese Acad Sci, Shanghai Key Lab Mol Androl, Grp Epigenet Reprogramming,Shanghai Inst Biol Sci, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China
[2] Univ Chinese Acad Sci, Beijing 100049, Peoples R China
[3] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Anim Core Facil, Shanghai 200031, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Lab Anim Ctr, Shanghai 201615, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China
基金
中国国家自然科学基金;
关键词
ONE-STEP GENERATION; CAS9; NUCLEASE; HUMAN-CELLS; GENOME; SYSTEM; MICE; SPECIFICITY; MUTATIONS; ELEGANS;
D O I
10.1016/j.stem.2013.10.016
中图分类号
Q813 [细胞工程];
学科分类号
摘要
The CRISPR-Cas9 system has been employed to generate mutant alleles in a range of different organisms. However, so far there have not been reports of use of this system for efficient correction of a genetic disease. Here we show that mice with a dominant mutation in Crygc gene that causes cataracts could be rescued by coinjection into zygotes of Cas9 mRNA and a single-guide RNA (sgRNA) targeting the mutant allele. Correction occurred via homology-directed repair (HDR) based on an exogenously supplied oligonucleotide or the endogenous WT allele, with only rare evidence of off-target modifications. The resulting mice were fertile and able to transmit the corrected allele to their progeny. Thus, our study provides proof of principle for use of the CRISPR-Cas9 system to correct genetic disease.
引用
收藏
页码:659 / 662
页数:4
相关论文
共 50 条
  • [31] Nanoparticles for CRISPR-Cas9 delivery
    Glass, Zachary
    Li, Yamin
    Xu, Qiaobing
    NATURE BIOMEDICAL ENGINEERING, 2017, 1 (11): : 854 - 855
  • [32] MicroRNAs tame CRISPR-Cas9
    Jouravleva, Karina
    Zamore, Phillip D.
    NATURE CELL BIOLOGY, 2019, 21 (04) : 416 - 417
  • [33] CRISPR-Cas9 wins Nobel
    Strzyz, Paulina
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (12) : 714 - 714
  • [34] Sperm and embryo genome editing by CRISPR-Cas9 in a mouse model
    De Jesus, A. B.
    Pizzo, E.
    Xie, P.
    Rosenwaks, Z.
    Palermo, G.
    HUMAN REPRODUCTION, 2024, 39 : I570 - I571
  • [35] CRISPR/Cas9-Mediated in vivo Genetic Correction in a Mouse Model of Hemophilia A
    Luo, Sanchuan
    Li, Zhongxiang
    Dai, Xin
    Zhang, Rui
    Liang, Zhibing
    Li, Wenzhou
    Zeng, Ming
    Su, Jinfeng
    Wang, Jun
    Liang, Xia
    Wu, Yong
    Liang, Desheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [36] The invisible dance of CRISPR-Cas9
    Palermo, Giulia
    Ricci, Clarisse G.
    McCammon, J. Andrew
    PHYSICS TODAY, 2019, 72 (04) : 30 - 36
  • [37] CRISPR-Cas9 in cancer therapeutics
    Randhawa, Shubhchintan
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 129 - 163
  • [38] CRISPR-Cas9 Structures and Mechanisms
    Jiang, Fuguo
    Doudna, Jennifer A.
    ANNUAL REVIEW OF BIOPHYSICS, VOL 46, 2017, 46 : 505 - 529
  • [39] Editing of mouse and human immunoglobulin genes by CRISPR-Cas9 system
    Taek-Chin Cheong
    Mara Compagno
    Roberto Chiarle
    Nature Communications, 7
  • [40] Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
    Yuxuan Wu
    Hai Zhou
    Xiaoying Fan
    Ying Zhang
    Man Zhang
    Yinghua Wang
    Zhenfei Xie
    Meizhu Bai
    Qi Yin
    Dan Liang
    Wei Tang
    Jiaoyang Liao
    Chikai Zhou
    Wujuan Liu
    Ping Zhu
    Hongshan Guo
    Hong Pan
    Chunlian Wu
    Huijuan Shi
    Ligang Wu
    Fuchou Tang
    Jinsong Li
    Cell Research, 2015, 25 : 67 - 79